Search

Background: The development of ultra-high-resolution CT (U-HRCT) is expected to improve the accuracy of coronary stenosis evaluation. This study aimed to evaluate the accuracy of the stenosis severities of coronary artery phantoms estimated using U-HRCT by comparing them to those estimated with conventional CT., Methods: Coronary artery phantoms with non-calcified and calcified lesions were scanned with conventional CT (64-row ​× ​0.625 ​mm) and U-HRCT (32-row ​× ​0.3125 ​mm). The coronary artery phantoms had lumen diameters of 2.0, 3.0, and 4.0 ​mm with non-calcified lesions representing 0%, 25%, 50%, and 75% stenosis and 3.0 and 4.0 ​mm with calcified lesions representing 0%, 25%, 50%, and 75% stenosis. The lumen diameters at the stenotic and non-stenotic regions were measured, and the stenosis severities were compared with the true values., Results: For non-calcified lesions, conventional CT significantly underestimated the stenosis severity in the phantom showing 75% stenosis with lumen diameters of 2.0 and 3.0 ​mm (p ​< ​0.05), while the estimated stenosis severities were not significantly different from the true values at all settings with U-HRCT. For the calcified lesions, conventional CT overestimated the stenosis severities at all settings (p ​< ​0.05), while U-HRCT yielded estimations closer to the true values, although still with some overestimation (p ​< ​0.05)., Conclusion: By using U-HRCT, the estimated stenosis severities of the coronary artery with non-calcified lesion become almost equal to the true value, while those with calcified lesion are still overestimated although they become closer to the true value., Competing Interests: Declaration of competing interest Sachio Kuribayashi received a grant from General Electric Healthcare Japan. However, the funder was not involved in the design of the study; collection, analysis, and interpretation of the data; or writing of the manuscript. All other authors have no conflict of interest to declare., (Copyright © 2021. Published by Elsevier Inc.)

Background: Whether coronary plaque characteristics assessed in coronary computed tomography angiography (CCTA) in association with the coronary artery calcium score (CACS) have predictive value for coronary events is unclear. We aimed to examine the predictive value of the CACS and plaque characteristics for the occurrence of coronary events., Methods: Among 2802 patients who were analyzed in the PREDICT registry, 2083 with suspected coronary artery disease (CAD) were studied using post hoc analysis. High-risk plaques were defined as having ≥2 adverse characteristics, such as low computed tomographic attenuation, positive remodeling, spotty calcification, and napkin-ring sign. An adjudicative composite of coronary events (cardiac death, nonfatal acute coronary syndrome, and coronary revascularization ≥3 months after indexed CCTA) were analyzed., Results: Seventy-three (3.5%) patients had coronary events and 313 (15.0%) had high-risk plaques. Multivariate Cox proportional hazard analysis showed that high-risk plaques remained an independent predictor of coronary events (adjusted hazard ratio [HR] 1.95, 95% confidence interval [CI] 1.13-3.34, P ​= ​0.0154), as well as the log-transformed CACS (adjusted HR 1.24, 95% CI 1.11-1.39, P ​= ​0.0002) and the presence of obstructive stenosis (adjusted HR 5.63, 95% CI 3.22-10.12, P 0.0001). In subgroup analyses, high-risk plaques were independently predictive only in the low CACS class (<100)., Conclusion: This study shows that assessment of adverse features by coronary plaque imaging independently predicts coronary events in patients with suspected CAD and a low CACS. Our findings suggest that the clinical value of high-risk plaques to CACS and stenosis assessment appears marginal., Competing Interests: Declaration of competing interest Yasuki Kihara received grants from Astellas Pharma, Actelion, Otsuka, MSD, Sanofi, Bayer, Shionogi, Saint-Judo Medical, Daiichi Sankyo, Takeda, Nippon Shinyaku Pharm, Boehringer-Ingelheim Japan, Biotonic, Bayer, Pfizer, Mochida Pharm, and Roche Diagnostics. Shinichiro Fujimoto received grants from HeartFlow Japan G.K, Canon Medical Systems Corporation, and Edwards LifeSciences Ltd., Hiroyuki Daida received remuneration for lectures from Amgen Astellas Biopharma K.K., Sanofi K.K., Daiichi-Sankyo Pharmaceutical Company Ltd., Terumo Corporation, Boehringer Ingelheim GmbH, Bayer AG, MSD K.K., Mitsubishi Tanabe Parma, Fujifilm, Fuji Chemical Co., Pfizer Pharmaceutical Company Ltd., and Canon Medical Systems Corporation. Shinichiro Fujimoto also received research grants from Nihon Medi-Physics Company Ltd., Kowa Pharmaceutical Company Ltd., Daiichi-Sankyo Company Ltd., Canon Medical Systems Corporation, Philips Respironics Ltd., Astellas Pharma Inc., Otsuka Pharmaceutical Company Ltd., Sanofi K.K., Boehringer Ingelheim GmbH, Bayer AG, Teijin Ltd., MSD K.K., Pfizer Pharmaceutical Company Ltd., HeartFlow, Novartis Pharma, Nihon Shinyaku, Fujifilm RI Pharm, and Actelion Pharmaceuticals Japan Ltd. Hiroyuki Daida is affiliated with some endowed departments, including Philips Respironics Ltd., Fukuda Denshi Company Ltd., and ResMed Ltd. Shunichi Miyazaki received grants from Boehringer-Ingelheim Japan, MSD, Astellas Pharma, Daiichi Sankyo, and Bayer. Tomohiro Kawasaki received grants from Abbot Vascular Japan, Boston Scientific Japan, Daiichi Sankyo Co., Japan Lifeline, and Astellas Amgen BioPharma. All other authors declare no competing interests., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)

Purpose: To compare the diagnostic performance of 320-detector row computed tomography (CT) coronary angiography-derived computed fractional flow reserve (FFR; FFRCT), transluminal attenuation gradient (TAG; TAG320), and CT coronary angiography alone to diagnose hemodynamically significant stenosis as determined by invasive FFR., Materials and Methods: This substudy of the prospective NXT study (no. NCT01757678) was approved by each participating institution's review board, and informed consent was obtained from all participants. Fifty-one consecutive patients who underwent 320-detector row CT coronary angiographic examination and invasive coronary angiography with FFR measurement were included. Independent core laboratories determined coronary artery disease severity by using CT coronary angiography, TAG320, FFRCT, and FFR. TAG320 is defined as the linear regression coefficient between luminal attenuation and axial distance from the coronary ostium. FFRCT was computed from CT coronary angiography data by using computational fluid dynamics technology. Diagnostic performance was evaluated and compared on a per-vessel basis by the area under the receiver operating characteristic (ROC) curve (AUC)., Results: Among 82 vessels, 24 lesions (29%) had ischemia by FFR (FFR ≤ 0.80). FFRCT exhibited a stronger correlation with invasive FFR compared with TAG320 (Spearman ρ, 0.78 vs 0.47, respectively). Overall per-vessel accuracy, sensitivity, specificity, and positive and negative predictive values for TAG320 (<15.37) were 78%, 58%, 86%, 64%, and 83%, respectively; and those of FFRCT were 83%, 92%, 79%, 65%, and 96%, respectively. ROC curve analysis showed a significantly larger AUC for FFRCT (0.93) compared with that for TAG320 (0.72; P = .003) and CT coronary angiography alone (0.68; P = .008)., Conclusion: FFRCT computed from 320-detector row CT coronary angiography provides better diagnostic performance for the diagnosis of hemodynamically significant coronary stenoses compared with CT coronary angiography and TAG320.

Background: Epicardial fat may play a role in the pathogenesis of coronary artery disease (CAD). We explored the relationship of epicardial fat volume (EFV) with the presence and severity of CAD or myocardial perfusion abnormalities in a diverse, symptomatic patient population., Methods and Results: Patients (n=380) with known or suspected CAD who underwent 320-detector row computed tomographic angiography, nuclear stress perfusion imaging, and clinically driven invasive coronary angiography for the CORE320 international study were included. EFV was defined as adipose tissue within the pericardial borders as assessed by computed tomography using semiautomatic software. We used linear and logistic regression models to assess the relationship of EFV with coronary calcium score, stenosis severity by quantitative coronary angiography, and myocardial perfusion abnormalities by single photon emission computed tomography (SPECT). Median EFV among patients (median age, 62.6 years) was 102 cm(3) (interquartile range: 53). A coronary calcium score of ≥1 was present in 83% of patients. Fifty-nine percent of patients had ≥1 coronary artery stenosis of ≥50% by quantitative coronary angiography, and 49% had abnormal myocardial perfusion results by SPECT. There were no significant associations between EFV and coronary artery calcium scanning, presence severity of ≥50% stenosis by quantitative coronary angiography, or abnormal myocardial perfusion by SPECT., Conclusions: In a diverse population of symptomatic patients referred for invasive coronary angiography, we did not find associations of EFV with the presence and severity of CAD or with myocardial perfusion abnormalities. The clinical significance of quantifying EFV remains uncertain but may relate to the pathophysiology of acute coronary events rather than the presence of atherosclerotic disease., (© 2015 American Heart Association, Inc.)

Aims: To evaluate the diagnostic power of integrating the results of computed tomography angiography (CTA) and CT myocardial perfusion (CTP) to identify coronary artery disease (CAD) defined as a flow limiting coronary artery stenosis causing a perfusion defect by single photon emission computed tomography (SPECT)., Methods and Results: We conducted a multicentre study to evaluate the accuracy of integrated CTA-CTP for the identification of patients with flow-limiting CAD defined by ≥50% stenosis by invasive coronary angiography (ICA) with a corresponding perfusion deficit on stress single photon emission computed tomography (SPECT/MPI). Sixteen centres enroled 381 patients who underwent combined CTA-CTP and SPECT/MPI prior to conventional coronary angiography. All four image modalities were analysed in blinded independent core laboratories. The prevalence of obstructive CAD defined by combined ICA-SPECT/MPI and ICA alone was 38 and 59%, respectively. The patient-based diagnostic accuracy defined by the area under the receiver operating characteristic curve (AUC) of integrated CTA-CTP for detecting or excluding flow-limiting CAD was 0.87 [95% confidence interval (CI): 0.84-0.91]. In patients without prior myocardial infarction, the AUC was 0.90 (95% CI: 0.87-0.94) and in patients without prior CAD the AUC for combined CTA-CTP was 0.93 (95% CI: 0.89-0.97). For the combination of a CTA stenosis ≥50% stenosis and a CTP perfusion deficit, the sensitivity, specificity, positive predictive, and negative predicative values (95% CI) were 80% (72-86), 74% (68-80), 65% (58-72), and 86% (80-90), respectively. For flow-limiting disease defined by ICA-SPECT/MPI, the accuracy of CTA was significantly increased by the addition of CTP at both the patient and vessel levels., Conclusions: The combination of CTA and perfusion correctly identifies patients with flow limiting CAD defined as ≥50 stenosis by ICA causing a perfusion defect by SPECT/MPI.

Objectives and Background: The objective of this study was to investigate the image quality-improving and heart rate-lowering effects of landiolol hydrochloride (a short-acting β1-adrenergic receptor blocker) on coronary computed tomography angiography (CCTA). During CCTA, β-adrenergic receptor blockers have been commonly used to lower heart rate and improve image quality., Methods: A total of 258 subjects suspected of having ischemic cardiac disease and requiring CCTA were randomized to either a landiolol hydrochloride 0.125 mg/kg group or placebo group to study the efficacy and safety of landiolol hydrochloride in a multicenter, double-blind, randomized parallel study. The primary endpoint was the diagnosable proportion (proportion of subjects whose coronary stenosis was diagnosable)., Results: The diagnosable proportions about the reconstruction images at mid-diastole were 68.2 and 38.2 % in the landiolol hydrochloride and placebo group, respectively, indicating significant superiority of landiolol hydrochloride over placebo (p < 0.0001). The diagnosable proportions about the optimal reconstruction images were 81.4 and 54.2 % in the landiolol hydrochloride and placebo group, respectively, indicating significant superiority of landiolol hydrochloride over placebo (p < 0.0001). The mean heart rate-lowering effect was first observed soon after administration of landiolol hydrochloride, was most marked at 3-5 min, and disappeared 30 min after completion of administration. The mean heart rate-lowering proportion at that time was -19.1 ± 8.1 % and -5.9 ± 9.7 % in the landiolol hydrochloride and placebo groups, respectively, showing a significantly higher proportion in the landiolol hydrochloride group., Conclusions: Landiolol hydrochloride was confirmed to significantly and rapidly lower heart rate after intravenous injection, suggesting that it is a safe and useful agent for improving the image quality of CCTA.

The purpose of this study was to evaluate improvement of measurement accuracy of in-stent lumen using coronary stent phantoms on new high-definition CT (HDCT) compared with conventional 64 detector-row CT (MDCT). To estimate the spatial resolution, a high-resolution insert of CATPHAN (The Phantom Laboratory, NY, USA) was scanned by both HDCT (Discovery CT750 HD) and MDCT (LightSpeed VCT). Also, we developed six types of stent phantom, which have 2.5- and 3.0-mm-diameter with three different types of stents (Velocity: Johnson & Johnson, Driver: Medtronic, Multilink-Rx: Guidant). A 50% stenotic segment made of acrylic resin was built at the center inside the stent. Those coronary vessel phantoms were made of acrylic resin and filled with diluted Iodine (350 HU in 120 kVp), and each stent was fixed inside of those vessels. Those phantoms in water-filled tank were scanned on both HDCT and MDCT. The luminal diameter obtained using digital calipers at five different points and the mean luminal diameter (MLD) were calculated. The underestimate ratio (UR) and △UR was defined as follows: UR = [True diameter of stent-MLD]/True diameter of stent; △UR = [MLD at HDCT-MLD at MDCT]/True diameter of stent. The spatial resolution was estimated to be 0.71 mm on MDCT and 0.50 mm on HDCT. At the non-stenotic segments, the △URs were 11.6% (Velocity), 16.4% (Driver) and 7.2% (Multilink) for the 2.5-mm stents, and 14.0% (Velocity), 16.3% (Driver) and 13.3% (Multilink) for the 3.0-mm stents. At the stenotic segment, the △URs were 23.2% (Velocity), 8.0% (Driver) and 13.6% (Multilink) for the 2.5-mm stents, and 20.0% (Velocity), 14.7% (Driver) and 15.3% (Multilink) for the 3.0-mm stents. Superior spatial resolution of HDCT could be promising for more accurate measurement of in-stent diameter.

A 74-year-old male underwent cardiac catheterization that revealed a chronic total occlusion of the proximal left anterior descending coronary artery (LAD). The right coronary artery provided only faint collateral circulation to the LAD. Multislice computed tomography (MDCT) disclosed that a conus artery took off directly from the aorta and provided good collateral circulation to the LAD. Percutaneous coronary intervention of the LAD was successfully performed using contralateral injection via the isolated conus artery. Whenever sufficient collateral filling is not visualized in a chronically occluded LAD, an isolated conus artery should be considered. MDCT is a helpful tool in this setting.

Background: The angiographic view (AGV) image is a new post-processing method that is similar to conventional coronary angiography (CAG). The purpose of this study was to evaluate its accuracy for coronary stenosis detection by 64-detector row computed tomography (CT)., Methods and Results: CT evaluation results of 17 patients were compared with the results of invasive CAG on a coronary segment basis concerning the presence of stenoses>50% diameter reduction. All images of the 3 viewing methods (combination of conventional methods, AGV image alone, and axial images alone) were evaluated in consensus by 3 cardiovascular radiologists. Among 196 assessable segments, invasive CAG showed significant coronary artery stenoses in 44 segments. 43 of 44 lesions were detected with the AGV image, and absence of significant stenosis was correctly identified in 135 of 152 segments (sensitivity 98%; specificity 89%; accuracy 91%; positive predictive value 72%, negative predictive value 99%). The sensitivity of the AGV image was the same as that of conventional methods (98%). There was no significant difference in accuracy between the AGV image (91%) and conventional methods (94%). The accuracy of the AGV image was significantly higher than the axial images alone (78%)., Conclusions: AGV image shows promise as a post-processing method for identifying coronary artery stenosis with high accuracy.

On rare occasions, extrinsic compression of the coronary artery can cause significant stenosis. We report a 42-year-old woman who was referred to our hospital for surgical repair of atrial septal defect. Cardiac 64-slice multi-detector computed tomography before the operation revealed the extrinsic compression of the proximal left main coronary artery by the marked dilatation of pulmonary trunk. The patient eventually underwent atrial septal defect closure and coronary artery bypass simultaneously. Four months after the operation, multi-detector computed tomographic scan revealed reduction of pulmonary trunk diameter and resolution of left main coronary artery narrowing.

The aim of this study was to determine the diagnostic performance of stress and rest perfusion magnetic resonance imaging (MRI) and late gadolinium-enhanced (LGE) MRI for identifying patients with obstructive coronary artery disease (CAD). A total of 50 patients with suspected CAD underwent stress-rest perfusion MRI, followed by LGE MRI with a 1.5-T system. Stress-rest perfusion MRI resulted in an area under the receiver-operating characteristic curve (AUC) of 0.92 for observer 1 and 0.84 for observer 2 with sensitivity and specificity of 89% (32/36) and 79% (11/14) by observer 1, 83% (30/36) and 71% (10/14) by observer 2, respectively, showing a moderate interobserver agreement (Cohen's kappa = 0.49). While combination of stress-rest perfusion and LGE MRI did not result in improved accuracy for the prediction of flow-limiting obstructive CAD (AUC 0.81 for observer 1 and 0.80 for observer 2), the sensitivity was increased to 92% in both observers with a substantial interobserver agreement (kappa = 0.70). Stress-rest myocardial perfusion MRI is an accurate diagnostic test for identifying patients with obstructive CAD.

Background: When using 16-slice multidetector-row computed tomography (MDCT) to detect coronary artery stenosis, coronary arteries measuring 1.5 mm or larger in lumen diameter are usually evaluated. The purpose of this study was to investigate the frequency of the visualized lumen in each coronary artery segment measuring more than 1.5 mm in diameter., Methods and Results: Electrocardiographic-gated 16-slice MDCT was used to scan 20 patients after administration of nitroglycerin. The luminal diameter of each coronary artery segment was measured on cross-sectional images using a caliper method. The frequency of the visualized lumen of each coronary artery segment measuring larger than 1.5 mm in diameter was as follows: #1: 100%, #2: 100%, #3: 100%, #4PD: 85%, #4AV: 80%, #5: 100%, #6: 100%, #7: 100%, #8: 90%, #9: 85%, #10: 40%, #11: 100%, #12: 65%, #13: 100%, #14: 80%. Averaged lumen diameter+/-standard deviation (mm) larger than 1.5 mm in all patients was calculated as follows: #1: 3.8+/-0.70, #2: 3.5+/-0.69, #3: 3.2+/-0.82, #5: 4.2+/-1.04, #6: 3.4 +/-0.79, #7: 2.9+/-0.62, #11: 2.9+/-0.69, #13: 2.6+/-0.57., Conclusion: Luminal diameter larger than 1.5 mm of each coronary artery segment can be assessed in most cases by 16-slice MDCT.

Objective: The purpose of this study is to consider the possibility of quantitative evaluation of coronary arterial stenosis by using 16-slice multidetector-row computed tomography (MDCT)., Methods: Simulated coronary arteries were prepared, which consist of 5-mm-diameter acryl tubes with contrast media (270 HU). Simulated stenoses of known density (-33 HU) were created in each coronary artery (25%, 50%, and 75%). Cardiac pulsating with 0, 50, 65, 85, and 105 beats per minute (bpm) was performed. Multiplanar reformation images for each coronary artery were created. Percent stenosis was calculated using the width middle value of boundary part of the arteries., Results: The stenoses were depicted in all heart rates. Average percent stenosis +/- standard deviation was 27.4 +/- 3.6%, 45.8 +/- 2.6%, and 69.4 +/- 2.7%, respectively. For each percent stenosis, there was a significant difference (P < 0.05)., Conclusion: Sixteen-slice MDCT has a potential for noninvasive quantitative evaluation of stenosis in coronary arteries.